Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Paternal valproate use not linked to offspring neurodevelopmental risks

19

Aug 2026

Paternal valproate use not linked to offspring neurodevelopmental risks

Use of the antiseizure drug valproate by fathers before conception is not associated with neurodevelopmental disorders like autism or attention-deficit/hyperactivity disorder (ADHD) in their children, according to a new study published August 19, 2026, in Neurology®, an official journal of the American Academy of Neurology.

Immediate access puts test results in patients’ hands, but the next challenge is making sense of them

19

Aug 2026

Immediate access puts test results in patients’ hands, but the next challenge is making sense of them

A nationally representative US study found that 68.6% of adults with access to medical records viewed immediately released test results before hearing from a healthcare practitioner. Among these viewers, only 34.9% rated their understanding as very good, with comprehension varying by region, digital literacy, patient-centered communication, and experiences of medical care discrimination.

A decades-long study raises questions about sugary drinks and stomach cancer

19

Aug 2026

A decades-long study raises questions about sugary drinks and stomach cancer

A large prospective U.S. study followed more than 111,000 adults to examine whether sugar-sweetened and artificially sweetened beverage intake was associated with gastric cancer incidence. Researchers identified 278 gastric cancer cases over 3.2 million person-years and found that associations differed according to beverage type and level of consumption.

Why pregnancy vaccination looks very different in Germany than it did 19 years ago

19

Aug 2026

Why pregnancy vaccination looks very different in Germany than it did 19 years ago

A 19-year German claims analysis of more than 2.8 million pregnancies found that recorded maternal vaccination increased substantially after national recommendations for influenza and pertussis immunization were introduced. Influenza vaccination reached 19.4% and pertussis vaccination about 37% in 2020-2022, while COVID-19 vaccination was not captured in the databas

Lower-calorie meals look cheaper, but there’s a catch in the price

19

Aug 2026

Lower-calorie meals look cheaper, but there’s a catch in the price

Analysis of 7,392 menu items from 200 large restaurant chains found that lower-calorie options on two major UK food delivery platforms carried a substantially higher cost per 100 kcal than higher-calorie items. The findings suggest that per-calorie pricing may create financial disincentives for choosing lower-calorie foods, with potential implications for diet-related health inequalities.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.